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eceptor tyrosine kinases play important roles in many aspects of developmental processes, including those of the melanocyte cell lineage (Molleman and Halaban, 1998; Hirobe et al, 1999) . c-Kit is the most extensively studied receptor tyrosine kinase in melanocyte precursors (melanoblasts); it is essential for the survival, growth, differentiation, and migration of melanoblasts. Its ligand, known as steel factor (hereafter called SLF, also named SCF, MGF, or KL), is produced by mesenchymal cells or keratinocytes (Wehrle-Haller and Weston, 1999) and stimulates c-Kit expressed on melanoblasts. As expected, mice with defects of the c-Kit or SLF gene develop a white or white spot phenotype caused by a complete lack or decrease of melanoblasts (Barsh, 1996) . Dependency of melanoblast development on c-Kit is well conserved even in zebla®sh (Parichy et al, 1999) , suggesting that molecular mechanisms of melanocyte development are evolutionarily conserved. Considering the obvious fact that melanocytes are an integrated component of the skin tissue, environmental cues including ligands for receptor tyrosine kinases must be utilized to maintain homeostasis of the skin system. In addition, these ligands may have a unique importance for understanding diseases related to melanocyte development.
WHAT KINDS OF RECEPTORS ARE EXPRESSED IN THE DEVELOPING MELANOCYTES?
Previous studies demonstrated expression of receptor tyrosine kinases in normal human melanocytes (Lee et al, 1993) . To avoid the signi®cant disregulation of gene expression in vitro cultures, we investigated the expression of receptor tyrosine kinases in normal melanoblasts puri®ed from neonatal skin. Reverse transcriptasepolymerase chain reaction (RT-PCR) and sequencing analysis revealed expression of four receptor tyrosine kinases known to affect melanocyte lineage cells (Fig 1) . Fibroblast growth factor (FGF) receptor and insulin receptor are essential for various cell types, and serum-free cultures of melanocytes require these two factors (Hirobe, 1992) . c-Kit is the receptor for SLF, which is known to be an essential factor for melanocyte development, as described above. c-Met, the receptor for hepatocyte growth factor (HGF), is also known to induce proliferation of cultured human melanocytes (Matsumoto et al, 1991) . Considering the ubiquitous expression of these receptors and the dependency on the ligands, FGF and insulin might not have melanocyte-speci®c functions. The role of c-met in melanocyte development has not been studied genetically because mutant mice that lack HGF or c-met are embryonic lethal around 13.5 dpc, possibly due to an essential function in organogenesis. The analysis of our limited number of RT-PCR-based cDNA clones suggests that novel receptor tyrosine kinases may not be expressed in developing melanoblasts.
SURVIVAL, PROLIFERATION, MIGRATION, OR DIFFERENTIATION: WHAT ARE THE ROLES OF LIGANDS FOR RECEPTOR TYROSINE KINASES IN MELANOCYTE DEVELOPMENT?
As developmental processes proceed seamlessly, classi®cation of the developmental processes into function-based categories is not so simple. For example, proliferation without survival is nonsense, and differentiation without proliferation occurs in some cases, but usually cells become differentiated while proliferating. In fact, as discussed by other authors (Galli et al, 1993) , SLF may contribute to every phase of cell development, including survival, proliferation, migration, and differentiation. In the case of melanocyte lineage cells, SLF supports their survival and proliferation of the neural crest cells prepared from isolated neural tubes (Murphy et al, 1992; Morrison-Graham and Weston, 1993) . In vivo administration of SLF to human skin induced pigmented spots in situ, suggesting the promotion of proliferation and differentiation of melanocytes by SLF (Grichnik et al, 1995) . In mouse skin, in contrast to human skin, melanocytes or their precursors cease growing after birth and disappear during the ®rst month of life except in hair follicles (Hirobe, 1984) . When expression of SLF was forced in the skin using transgenic mice, melanocytes continued to reside in the epidermis of the skin.
promotes survival and proliferation of melanocytes or their precursors (Kunisada et al, 1998a) . Exogenous SLF does not simply promote proliferation of mature melanocytes, because unpigmented TRP2-positive and c-Kit-positive melanoblasts were observed in the epidermis of SLF transgenic skin. In addition, regions that no melanocytes normally reach at any stage of development, such as the oral epithelium and the tooth gum, were heavily pigmented in SLF transgenic mice, suggesting that SLF has the ability to stimulate migration of melanoblasts (Kunisada et al, 1998b) . The expression pattern of SLF as related to possible effects on melanocytes and experimentally observed biological effects of SLF on melanocyte development are summarized in Table I .
By the same strategy of inducing ectopic expression of the ligand molecule in transgenic mice, HGF was also found to be able to promote survival, proliferation, and differentiation of melanocytes (Kunisada et al 2000) . The function of ectopic HGF in melanocytes overlapped considerably with that of SLF.
In these two cases, the possibility that these ligands for receptor tyrosine kinases act only to stimulate the growth of melanocytes was clearly ruled out; however, at least in the skin of laboratory mice, mature fully pigmented melanocytes are rarely observed, except in hair follicles and unhaired skin such as ears, lips, or external genitalia. In the transgenic animals described above, a number of mature melanocytes were detected as early as the newborn stage, indicating that a single ligand molecule could change the skin environment so as to support survival, proliferation, and differentiation of melanocytes. If the ligands stimulate only survival and proliferation, the skin should be occupied by undifferentiated melanoblasts instead of pigmented melanocytes. Although indirect effects of these ligands, e.g., via keratinocytes, are possible, it is still true that the ligand-furnished skin environment supports survival, proliferation, differentiation, and in case of SLF, migration of melanocyte lineage cells.
An interesting difference was also observed between these two kinds of transgenic mice. Most of the melanocytes were observed in the basal layer of the epidermis, where the cytokeratin promoter directs the transgene expression, as expected, in the case of SLF transgenic mice (Kunisada et al, 1998a, b) . In contrast, melanocytes were mostly located in the dermis in all three independent lines of HGF transgenic mice (Kunisada et al, 2000) , whereas immunohistochemical analysis con®rmed epidermal expression of HGF molecules in the transgenic skin. The ligand molecules might have the more subtle regulatory function as to where in the skin melanocytes should be located. Interestingly, the ear of the normal mouse, in which dermal melanocytes are the major population, expressed a higher level of HGF mRNA than haired skin, suggesting that the dermal melanocytes induced by HGF might not be an extreme case caused by the abnormal skin environment affected by the ectopic expression of HGF.
RELATIONSHIP OF THE SIGNALING BY STEEL FACTOR OR HGF WITH THE SIGNALING MEDIATED BY ENDOTHELIN 3
Endothelin 3 (ET3) is one of the essential factors for the early development of melanocytes. Mice with ET3 mutations (lethal spotted, ls/ls, Baynash et al, 1994) or mutations of its G-proteincoupled receptor, endothelin receptor-B (piebald lethal, s l /s l , Hosoda et al, 1994) show similar white spots, indicating the essential function of ET3 for melanocyte development. By using the tetracycline induction system in vivo, the critical period when melanocytes depend on ET3 was determined to extend from 10.5 dpc to 12.5 dpc (Shin et al, 1999) . Even gene-targeted null mutants of ET3 and endothelin receptor-B mice do not completely lose their melanocytes, suggesting that ET3 signaling might not be indispensable for survival and/or growth of melanoblasts, but rather required for their migration. In fact, the migration activity of melanoblasts is most prominent during 10.5±13.5 dpc . In ls/ls mice, melanoblasts appear as early as 10.5 dpc, but stay in the head and tail regions until 13.5 dpc, and then start to migrate and ®nally cover most of the coat, except for the trunk region . After 13.5 dpc, SLF may act or compensate for the ET3 activity for melanoblast migration. ET3 stimulates proliferation and differentiation of melanocytes, at least in vitro, as does SLF (Lahav et al, 1996; Reid et al, 1996) . Even in the presence of ET3, the function-blocking antibody for c-Kit completely abolishes the generation of melanocytes, indicating that ET3 and c-Kit are independently required for the survival and/or proliferation of melanocyte lineage cells (Yoshida et al, unpublished observation) . ET3 might affect another phase of melanocyte differentiation, because melanocytes cultured in the presence of ET3 are excessively pigmented and highly dendritic in shape compared with the melanocytes induced by SLF (Lahav et al, 1996) . Another unique function of ET3 is the induction of glial cell precursors from fully mature melanocytes (Dupin et al, 2000) . This Figure 1 . Receptor tyrosine kinases expressed in the skin melanocyte precursors. (A) Dorsal trunk skin was prepared from newborn C57BL/6 mice. After pieces of skin were washed three times with phosphate-buffered saline (PBS), they were incubated in PBS containing 0.25% trypsin, and then epidermal sheets were pealed off and dissociated in the presence of 0.02%EDTA, as described in detail by Hirobe (1992) . The epidermal cells harvested were then resuspended in Hanks' balanced salt solution containing 10% rabbit serum, and stained with PE-conjugated anti-c-Kit antibody (ACK4) and FITC-conjugated anti-CD45 antibody as described by Kunisada et al (1996) . After sorting the c-Kit + CD45-fraction enclosed by the broken line, the cells were pelleted and total cellular RNA was puri®ed using ISOGEN. The purity of the sorted cells was more than 95%, as assessed by the re-analysis bȳ ow cytometry. (B) Two micrograms of isolated RNA was used to perform reverse transcription using odigo dT primers, and 1/10 of the reaction was used for the PCR reaction by using degenerate primers PTKI and PTKII as detailed in Ogawa et al (1998) . Ampli®ed DNA fragments were puri®ed by agarose gel electrophoresis, cloned into PCR2.1 vector and sequenced. A total of 60 clones containing protein kinase sequences were analyzed to determine their nucleotide sequences and identities. VOL. 6, NO. 1 NOVEMBER 2001 unusual change of cell lineage is a phenomenon known as transdifferentiation. Whether SLF or HGF play a role in this transdifferentiation caused by ET3 is not known.
ROLES OF LIGAND MOLECULES IN THE DEVELOPMENT OF MELANOMAS
The development of cancer is closely associated with normal differentiation pathways. Therefore, factors that act in the course of normal development may provide keys to understanding mechanisms of neoplastic transformation, in this case, transformation to melanomas. When HGF is expressed in the whole body under the control of a metallothionein promoter sequence, melanocyte occurs in both the dermis and the epidermis (Takayama et al, 1997) . In addition, tumors, including melanomas, are frequently observed. Metallothionein may induce HGF expression in all cells including melanocytes themselves, and an autocrine loop formed between c-Met expressed in melanocytes is then essential for neoplastic transformation. In contrast, in k14-HGF transgenic mice, melanomas and other tumors are rarely observed. In this type of transgenic mouse, HGF is supplied only from keratinocytes. The mode of ligand supply, autocrine or paracrine, may determine the fate of melanocytes. Alternatively, it is possible that the crucial point is not the mode of the ligand supply but the amount of the ligand; in other words, the metallothionein promoter may simply produce more ligand molecules. We currently do not favor this possibility, because the extent of pigmentation and the number of melanocytes in the skin are comparable in these two types of transgenic mice, indicating that the amount of HGF produced and the amount of signaling through c-Met may not be very different. Furthermore, the serum concentration of HGF in metallothionein-HGF transgenic mice is 16 ng per ml (Takayama et al, 1996) and that in k14-HGF transgenic mice is 10 ng per ml (unpublished observations). In k14-SLF transgenic mice, no signi®cant melanoma development has been observed during more than 6 years of their maintenance (Kunisada et al, unpublished observation) . These observations support the idea that it is not the amount of HGF produced in the local environment, but rather the mode of ligand supply, that is important for malignant transformation.
A QUESTION THAT WE COULD NOT ANSWER
One of the prominent features of melanocytes is their strong ability to migrate and eventually cover the whole body. This in turn raises the question of why melanocytes cover the whole body without accumulating in the most distal parts such as the belly or tail. The mechanism enabling the uniform distribution of melanocytes might be a yet unknown and important feature of melanocytes. Targeted expression of SLF in the basal layer of the skin actually extended melanocyte distribution; still, melanocytes seemed to be evenly distributed. In this case of k14-SLF transgenic mice, melanoblasts of 14.5 dpc embryos were observed to occupy the oral epithelium, suggesting that melanocyte precursors have an intrinsic tendency to migrate under the suitable environment. The simple assumption that some melanoblasts are not migratory and some are extremely migratory may explain the even distribution of melanocytes throughout the skin. More precisely, the presence or maintenance of more immature, more migratory melanoblasts is the ®rst requisite. The existence of such melanocyte stem cells is suggested by the phenomenon of adult hair regeneration. In each hair cycle, not only keratinocytes but also melanocytes were regenerated from a small number of stem cells. No direct evidence of melanocyte stem cells is available, but the presence of these cells is suggested by the fact that putative melanocyte stem cells in the adult hair follicles are maintained in a c-Kit-independent manner (Nishikawa et al, 1991) . Segregation or maintenance of a small number of In situ hybridization SLF transcripts are present in the ectoderm of whisker follicles, around the otic vesicle, developing ear and dermis (but not the epidermis).
Matsui et al, 1990
In situ hybridization Expression of SLF in developing dermal skin at least from E13.0. Later in development, SLF expression decreases markedly. Keshet et al, 1991 lacZ activity in transgenic mice SLF expression in embryonic dermal skin and dermal papillae of hair follicles was veri®ed using SLF promoter-lacZ transgenic mice.
Yoshida et al, 1996
In vitro administration of recombinant SLF Normal human melanocytes proliferate in vitro when SLF is provided with PMA, but SLF alone has little effect. In the ®ve of eight human melanomas tested, c-Kit was not constitutively hybridization activated.
Funasaka et al, 1992
In vitro administration of recombinant SLF
In contrast to the effects on normal melanocytes, SLF inhibited rather than stimulated the growth of metastatic melanoma cell lines.
Zact et al, 1993
In vitro administration of recombinant SLF Random chemokinetic movement of cultured melanocytes was induced by SLF in vitro, and also by basic ®broblast growth factor, leukotriene C4, and endothelin-1.
Horikawa et al, 1995
In vitro administration of recombinant SLF SLF supported the maintenance of melanoblasts but did not stimulate their ®nal maturation. Murphy et al, 1992 In vitro administration of recombinant SLF SLF acts primarily as a survival factor for melanoblasts derived from cultured neural crest cells. At higher concentrations, SLF enhanced the ®nal stages of melanogenesis in vitro.
Morrison-Graham and Weston, 1993 In vitro administration of recombinant SLF Survival and proliferation of c-kit+TRP2+ melanoblasts but not other lineages were observed in mouse cultured neural crest cells. Reid et al, 1995 In vitro administration of recombinant SLF (isolated embryonic skin)
Implanted SLF beads did not stimulate melanoblast migration towards the bead, rather melanocyte localization in the follicles was accelerated. This indicates simple promotion of melanocyte motility by SLF.
Jordan and Jackson, 2000
In vivo expression of SLF Targeted expression of SLF in mouse skin promoted survival, proliferation, differentiation, and migration of melanocyte precursors. Kunisada et al, 1998b In vivo administration of recombinant SLF Skin at the site of SLF injection (14 d of 5 mg per kg) had an increased number of melanocytes, increased melanocytic dendrite extension, and increased melanin.
Grichnik et al, 1995
In vivo administration of recombinant SLF Daily application of r-hSLF induced hyperpigmentation at least during the initial 14 d of administration. In humans, r-hSLF-induced hypermelanosis occurs before the onset of melanocytic hyperplasia.
Costa et al, 1996
In vivo administration of recombinant SLF Human skin xenografts treated with r-hSLF showed increased number, size, and dendricity of melanocytes. Grichnik et al, 1998 melanocyte stem cells is assumed to occur during proliferation and differentiation of melanoblasts. In a colony derived from melanocyte stem cells, at least one cell is maintained as a stem cell, and later this cell migrates away and forms a new colony. In any case, ligands for receptor tyrosine kinases play essential roles in the migration of melanoblasts in vivo, as indicated by the experiments involving ectopic expression of the ligands. Some diseases characterized by hypo-or hyper-pigmentation may presumably be a manifestation of altered receptor tyrosine kinase signaling, which stimulates the migration of melanocyte lineage cells.
FUTURE PROSPECTS
Recently, a different type of secreted factors, Wnt family proteins, were reported to affect melanocyte differentiation, at least in zebra®sh (Dorsky et al, 1998) . In zebra®sh, Wnt is used to select the neural crest cell fate to either neuronal cells or melanocytes. There must be additional environmental factors that regulate melanocyte development, and searching for these molecules is important in order to fully understand the early developmental processes of melanocyte lineages. The link between the signals from receptor tyrosine kinases and transcription factors controlling melanocyte development is still uncertain. It was reported that MITF, a basichelix-loop-helix-zipper transcription factor, alone could induce NIH3T3 cells to develop into melanocytes (Tachibana et al, 1996) . c-Kit signaling may cause phosphorylation of MITF through a MAP kinase pathway (Goding, 2000) . At least in cultured mast cells, MITF could also induce c-Kit expression. In any case, MITF is currently the only known transcription factor that leads to expression of melanocyte-speci®c genes.
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